CVS
CVS Health Corporation
$93.26
-$0.06(-0.06%)
69
Overall
80
Value
66
Tech
63
Quality
Market Cap
$103.91B
Volume
4.84M
52W Range
$58.50 - $98.43
Target Price
$101.17
Order:
Income Statement
| Metric | Trend | Chart | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $177.5B | $184.8B | $193.9B | $255.8B | $267.9B | $290.9B | $85.3B | $99.2B | $122.9B | $134.8B | ||
| Total Revenue | $177.5B | $184.8B | $194.6B | $256.8B | $268.7B | $292.1B | $322.5B | $357.8B | $372.8B | $402.1B | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $148.7B | $153.4B | $156.4B | $158.7B | $219.7B | $240.0B | $196.9B | $217.1B | $206.3B | $221.2B | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $28.9B | $31.3B | $38.1B | $98.1B | $49.0B | $52.1B | $125.6B | $140.7B | $166.5B | $180.9B | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $18.5B | $18.8B | $21.4B | $-4.0M | $-3.0M | $-3.0M | $38.2B | $126.1B | $41.7B | $45.0B | ||
| Research & Development | -- | -- | -- | -- | -- | -- | -- | $86.2B | -- | -- | ||
| Research Expense | -- | -- | -- | -- | -- | -- | -- | $86.2B | -- | -- | ||
| Selling, General & Administrative | $148.7B | -- | $6.6B | -- | -- | -- | -- | -- | -- | -- | ||
| Selling & Marketing Expenses | $216.0M | $230.0M | $364.0M | $396.0M | $461.0M | $707.0M | $745.0M | $985.0M | $989.0M | -- | ||
| General & Administrative Expenses | $-24.0M | $153.0M | $141.0M | $111.0M | -- | -- | -- | -- | -- | -- | ||
| Promotion & Advertising | $216.0M | $230.0M | $364.0M | $396.0M | $461.0M | $707.0M | -- | -- | -- | -- | ||
| Salaries & Wages | $-22.0M | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Depreciation & Amortization | $2.5B | $2.5B | $2.7B | $4.4B | $4.4B | $4.5B | $4.2B | $4.4B | $4.6B | -- | ||
| Depreciation & Amortization | $2.5B | $156.2B | $2.7B | $4.4B | $4.4B | $4.5B | -- | -- | -- | -- | ||
| Amortization | $38.2B | $38.5B | $-398.0M | $79.8B | $-449.0M | $79.2B | $78.4B | $91.5B | $2.0B | $2.0B | ||
| Other Operating Expenses | $18.5B | $18.8B | $21.4B | $-4.0M | $-3.0M | $-3.0M | $38.2B | $39.8B | $41.7B | $45.0B | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $10.4B | $9.5B | $4.0B | $12.0B | $13.9B | $13.2B | $8.0B | $13.7B | $8.5B | $4.7B | ||
| EBITDA | $12.2B | $11.8B | $6.7B | $16.4B | $17.1B | $17.5B | $12.3B | $18.2B | $13.7B | $9.9B | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $1.1B | $1.1B | $2.6B | $3.0B | $2.9B | $2.5B | $2.3B | $2.7B | $3.0B | $3.1B | ||
| Intinc | $20.0M | $21.0M | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Net Non-Operating Interest Income/Expense | $-1.1B | $-1.1B | $-2.6B | $-3.0B | $-2.9B | $-2.5B | $-2.3B | $-73.0M | $-3.0B | $-3.1B | ||
| Gain on Sale of Securities | -- | $21.0M | $660.0M | $1.0B | $798.0M | $1.2B | $838.0M | $1.2B | $2.2B | $2.2B | ||
| Other Income/Expense | $149.3B | $3.0B | $5.9B | $51.5B | $56.1B | $63.3B | $72.6B | $-892.0M | $-2.7B | $-2.8B | ||
| Other Special Charges | $-671.0M | $-208.0M | $-6.6B | $-52.5B | $-56.9B | $-64.5B | $-70.9B | $88.0M | $590.0M | $112.0M | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | -- | $-6.8B | $-1.2B | -- | -- | -- | -- | $507.0M | $1.2B | $125.5B | ||
| Special Income Charges | -- | $-181.0M | $-6.1B | $24.0M | -- | $-431.0M | $-5.8B | $-507.0M | $-116.3B | $-131.3B | ||
| Impairment of Capital Assets | -- | $181.0M | $6.1B | -- | -- | $431.0M | -- | $152.0M | $115.1B | $5.7B | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $9.7B | $9.3B | $4.0B | $12.0B | $12.7B | $13.0B | $8.1B | $13.8B | $9.1B | $5.3B | ||
| Pre-Tax Income | $8.6B | $8.3B | $1.4B | $9.0B | $9.8B | $10.4B | $5.8B | $11.2B | $6.1B | $2.1B | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $3.3B | $1.6B | $2.0B | $2.4B | $2.6B | $2.5B | $1.5B | $2.8B | $1.6B | $408.0M | ||
| NET INCOME | ||||||||||||
| Net Income | $5.3B | $6.6B | $-594.0M | $6.6B | $7.2B | $8.0B | $4.3B | $8.3B | $4.6B | $1.8B | ||
| Net Income (Continuing Operations) | $5.3B | $6.6B | $-594.0M | $6.6B | $7.2B | $7.9B | $4.3B | $8.4B | $4.6B | $1.7B | ||
| Net Income (Discontinued Operations) | $5.3B | $6.6B | $-594.0M | $6.6B | $7.2B | $8.0B | $4.3B | $8.3B | $4.6B | $1.8B | ||
| Net Income (Common Stockholders) | $5.3B | $6.6B | $-594.0M | $73.7B | $7.2B | $8.0B | $4.3B | $8.3B | $4.6B | $1.8B | ||
| Normalized Income | $5.6B | $-234.4B | $-237.2B | $7.8B | $7.5B | -- | -- | -- | -- | $133.0B | ||
| TOTALS | ||||||||||||
| Total Expenses | $167.2B | $172.3B | $177.8B | $158.7B | $164.0B | $175.8B | $235.1B | $343.2B | $248.0B | $266.1B | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $1.1B | $1.0B | $1.0B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | ||
| Average Shares Outstanding (Diluted) | $1.1B | $1.0B | $1.0B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | ||
| Shares Outstanding | $1.0B | $1.0B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | ||
| Basic EPS | $4.93 | $6.47 | $-0.57 | $5.1 | $5.48 | $6 | $3.16 | $6.49 | $3.67 | $1.4 | ||
| Basic EPS (Continuing Operations) | $4.93 | $6.48 | $-0.57 | $5.1 | $5.49 | $6 | $3.16 | $6.49 | $3.67 | $1.4 | ||
| Diluted EPS | $4.91 | $6.44 | $-0.57 | $5.08 | $5.46 | $5.95 | $3.14 | $6.47 | $3.66 | $1.39 | ||
| Diluted EPS (Continuing Operations) | $4.91 | $6.45 | $-0.57 | $5.08 | $5.47 | $5.95 | $3.14 | $6.47 | $3.66 | $1.39 | ||
| Dividend Per Share | $1.72 | $2 | $2 | $2 | $2 | $2 | $2.42 | $2.66 | $2.66 | $2.66 | ||
| OTHER METRICS | ||||||||||||
| Allowances For Construction | $148.7B | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Basic Discontinuous Operations | -- | $-0.01 | -- | -- | $-0.01 | -- | -- | -- | -- | -- | ||
| Depletion | -- | $156.2B | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Diluted Discontinuous Operations | -- | $-0.01 | -- | -- | $-0.01 | -- | -- | -- | -- | -- | ||
| Gain On Sale Of Business | -- | -- | $86.0M | $-205.0M | $269.0M | -- | -- | -- | -- | $483.0M | ||
| Minority Interests | $-2.0M | $-1.0M | $2.0M | $3.0M | $-13.0M | $12.0M | $-16.0M | $-24.0M | $28.0M | $40.0M | ||
| Net Income Discontinuous Operations | $-1.0M | $-8.0M | $-86.0M | $-205.0M | $-9.0M | -- | -- | -- | -- | -- | ||
| Non Recurring Operation Expense | -- | -- | -- | -- | -- | -- | $5.8B | -- | $100.0M | -- | ||
| Other Gain Loss From Disposition Of Discontinued Operations | $-1.0M | $-8.0M | -- | -- | $-9.0M | -- | -- | -- | -- | -- | ||
| Other Gand A | $-24.0M | $153.0M | $141.0M | $111.0M | -- | -- | -- | -- | -- | -- | ||
| Other Impairment Of Capital Assets | -- | -- | -- | -- | -- | -- | $2.5B | $349.0M | -- | -- | ||
| Other Write Off | -- | $2.8B | $37.0M | $79.0M | $-307.0M | -- | -- | -- | -- | -- | ||
| Provision For Gain Loss On Disposal | -- | -- | $-86.0M | $-205.0M | $269.0M | -- | -- | -- | -- | -- | ||
| Rent And Landing Fees | $-24.0M | $-24.0M | $-21.0M | -- | -- | -- | -- | -- | -- | -- | ||
| Selling Expense | $148.7B | -- | $6.6B | -- | -- | -- | -- | -- | -- | -- | ||
| Write Down | -- | -- | -- | $-24.0M | -- | -- | -- | -- | -- | -- | ||
| Othspecchg | -- | -- | -- | -- | -- | -- | -- | -- | $115.1B | -- | ||
| Restruct | -- | $-6.8B | $-1.2B | -- | -- | -- | -- | $507.0M | $1.2B | $125.5B | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CVS | $93.26 | -0.1% | 4.84M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |